Strategic Alignment Abigo Medical sits within Essity's Health & Medical portfolio, creating a channel for cross selling Sorbact based dressings through Essity's global sales network. The ownership alignment enables coordinated marketing with Essity's hygiene and infection control solutions and may lead to longer term contract opportunities with large healthcare providers.

Channel Expansion Leverage Essity backing and Abigo's lean team to scale through established international distributors and hospital networks. Focus on wound care departments in Europe and other regions with infection control priorities, offering Sorbact technology as a non antibiotic option while speeding market entry with shared regulatory and quality acceleration.

Wound Care Growth Position Sorbact technology as a bacteria removal approach that supports antimicrobial stewardship and reduces antibiotic use in wound management. Target chronic wounds, burn units, and post surgical care within hospitals and long term care settings, appealing to procurement teams focused on patient safety and outcomes.

Manufacturing Partnerships Explore OEM, white label, or licensing opportunities to co develop and manufacture Sorbact based dressings for other brands or distributors. Leverage Abigo's development and manufacturing focus to scale quickly without heavy capex, while expanding product formats and applications.

Sustainability & Compliance Emphasize sustainability and regulatory readiness supported by Essity to accelerate go to market for compliant, eco mindful wound care solutions. Target healthcare buyers with procurement programs prioritizing hygiene and environmental impact, and align with regulatory pathways to speed approvals in key regions.